Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regional serotonin receptor studies: chronic methysergide treatment induces a selective and dose-dependent decrease

P C May, D G Morgan, C E Finch

    Life Sciences
    |May 12, 1986
    PubMed
    Summary

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Higher blood lipid levels after the transition to menopause in two forager-horticulturalist populations.

    Evolution, medicine, and public health·2025
    Same author

    Three distinct hematological malignancies from a single germ cell tumor: a case report.

    Journal of medical case reports·2020
    Same author

    APOE genotype and sex affect microglial interactions with plaques in Alzheimer's disease mice.

    Acta neuropathologica communications·2019
    Same author

    Prenatal and early life exposure to air pollution induced hippocampal vascular leakage and impaired neurogenesis in association with behavioral deficits.

    Translational psychiatry·2018
    Same author

    Comment on "The plateau of human mortality: Demography of longevity pioneers".

    Science (New York, N.Y.)·2018
    Same author

    Letter: NICE referral criteria for lower gastrointestinal alarm features - not ideal but not poor either. Authors' reply.

    Alimentary pharmacology & therapeutics·2017

    Chronic methysergide treatment did not alter serotonin-1 (S-1) receptors but decreased serotonin-2 (S-2) receptors in mice. This atypical response suggests unique serotonin receptor regulation or presynaptic effects of methysergide.

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Receptor Biology

    Background:

    • Regulation of serotonin receptors, particularly serotonin-1 (S-1) and serotonin-2 (S-2) receptors, remains poorly understood compared to dopaminergic and beta-adrenergic systems.
    • Supersensitization responses in other receptor systems to antagonists and denervation are well-documented.

    Purpose of the Study:

    • To investigate the effects of chronic methysergide administration on S-1 and S-2 receptor regulation in the mouse brain.
    • To determine if methysergide, a serotonin antagonist, modulates receptor affinity or density.

    Main Methods:

    • Male C57BL/6J mice received chronic treatment with methysergide.
    • Radioligand binding assays were used to measure the affinity and density of S-1 receptors (using [3H]-5-HT) and S-2 receptors (using [3H]-spiperone) in specific brain regions.

    Related Experiment Videos

  • Dopamine D-2 receptor binding ([3H]-spiperone) in the caudate nucleus was also assessed to confirm selectivity.

    • Main Results:

    • Methysergide treatment did not affect the affinity or density of S-1 receptors in the cerebral cortex, hippocampus, or hypothalamus.
    • A dose-dependent decrease in S-2 receptor specific binding was observed in the cerebral cortex following methysergide treatment.
    • This effect was selective for S-2 receptors, as D-2 dopaminergic receptor binding in the caudate nucleus remained unchanged.

    Conclusions:

    • Serotonin receptors may exhibit atypical responses to chronic antagonist blockade compared to other neurotransmitter systems.
    • Methysergide's in vivo actions might involve presynaptic mechanisms affecting serotonin uptake or release, contributing to the observed downregulation of S-2 receptors.
    • Further research is needed to elucidate the precise mechanisms underlying serotonin receptor regulation by antagonists.